Auron Therapeutics, Inc.

CIK 1746139 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Auron Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 13, 2026D0001746139-26-000002
Dec 23, 2025D/A0001746139-25-000003
Dec 31, 2024D0001746139-24-000003
Oct 20, 2023D/A0001746139-23-000002
Jul 28, 2022D0001746139-22-000001
Dec 16, 2020D0001746139-20-000001
Jul 25, 2018D0001746139-18-000001